The team at Cooley (UK) LLP is jointly overseen by John Wilkinson, known for his prowess in handling large-scale alliances and joint ventures, and Nicola Maguire, who handles a range of IP and transactional issues such as high-profile collaborations and strategic investments. Transactional work is a mainstay of the practice with series investments and debt and equity financings notable areas of activity. Colm Murphy is geared to assist life sciences clients with their IP strategy, while Frances Stocks Allen excels in handling the IP aspects of major life sciences deals. Joe Sandys further extends the unit’s transactional expertise and frequently advises on licensing and M&A matters.
Testimonials
Collated independently by Legal 500 research team.
‘I have worked with several different law firms over the years and what makes Cooley stand out is the way that pragmatism and flexibility is combined with a high degree of expertise that allows rapid project engagement and understanding of what we need as a client, as well as the ability to focus on the key issues. ’
‘The Cooley team is very friendly, informal and easy to collaborate with. There is high attention to detail and high quality in the work.'
Key clients
- Allergy Therapeutics plc
- Athenex
Work highlights
- Advised Quell Therapeutics, a leading T-regulatory (Treg) cell therapy biotech company based in London, on its exclusive collaboration with AstraZeneca.
- Advised Bicycle on a noteworthy follow-on offering. After closing lucrative collaboration deals with Novartis and Bayer, Bicycle executed a US$230 million follow on of ADS and non-voting ordinary shares.